As elevations in plasma glucagon concentrations are implicated with hepatic steatosis [29], independent of insulin resistance, these results suggest that reduced ICR is a consequence of intra-hepatic lipid accumulation rather than insulin resistance per se. This evidence concerns the gene GCG and fatty liver disease.